Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by auburn2

T.ACX

RE:RE:gaining market share

revvenue is barely down from june 2018 when the share price was $1.20. sell...

August 20, 2019

T.ACX

gaining market share

see the latest press release.

August 20, 2019

T.YGR

RE:RE:RE:RE:Couple of points...

They went from 58% liquids to 47% liquids from Q408 to Q209. They're now...

August 19, 2019

T.YGR

RE:Couple of points...

kavern, totally different situation with ATH. Lower net debt, much higher...

August 19, 2019

T.YGR

RE:RE:RE:Couple of points...

scares away buying power.

August 19, 2019

T.YGR

RE:RE:Couple of points...

They can't afford to risk a reduction to their bank line. Spending scarce...

August 19, 2019

T.YGR

RE:"auburn2" alias case and his BXE, PONY, PD, STEP, MND, ALO

No. Stockfy lies and projects. He's a big promoter whose winners include...

August 16, 2019

T.YGR

RE:RE:Current decline rate

Something else I found. "I spoke with management and asked about the...

August 15, 2019

T.YGR

RE:Current decline rate

ATH proudly says "Maturing cash flow profile with strong sustainability...

August 15, 2019

T.YGR

Current decline rate

Do you know what it is? I found "The Company's base corporate...

August 15, 2019

T.YGR

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Minimal free cash flow

derbon, ygr isnt growing much anymore. q4 was a once in a lifetime thing for...

August 15, 2019

T.YGR

RE:RE:RE:RE:RE:RE:RE:RE:Minimal free cash flow

ATH looks a bit better. $135 million capex to sustain 34,000 boe/d of 85...

August 14, 2019

T.YGR

RE:RE:RE:RE:RE:RE:RE:Minimal free cash flow

Those low costs are just distractions. Bottom line is they are just lucky to...

August 14, 2019

T.YGR

RE:RE:RE:RE:RE:Minimal free cash flow

Like I say, NAV doesn't really mean anything except how long they have...

August 14, 2019

T.YGR

RE:RE:RE:RE:Minimal free cash flow

All I'm saying is they're spending $100 million on capex. That's...

August 14, 2019

T.YGR

RE:RE:Minimal free cash flow

140 million is over 40% higher than 100 million. How are they going to grow...

August 14, 2019

T.YGR

RE:Minimal free cash flow

"With the stock trading in line with peers on strip pricing at 4.1 times...

August 14, 2019

T.YGR

Minimal free cash flow

Notice: "The company's relatively active, $100-million 2019 capital...

August 14, 2019

T.YGR

RE:Idiocy...

"Recently adopted a formal diversity policy to acknowledge important...

August 14, 2019

T.YGR

Idiocy...

47% liquids. $180 million of debt. It amazes me the junk people buy when they...

August 14, 2019

Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next

Featured Company

Innocan Pharma Corp

Innocan Pharma Corp C.INNO

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the ... view more »